Lois Shepherd

Lois Shepherd

UNVERIFIED PROFILE

Are you Lois Shepherd?   Register this Author

Register author
Lois Shepherd

Lois Shepherd

Publications by authors named "Lois Shepherd"

Are you Lois Shepherd?   Register this Author

100Publications

3124Reads

24Profile Views

Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.

Clin Epigenetics 2019 Nov 1;11(1):155. Epub 2019 Nov 1.

Division of Cancer Biology and Genetics, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-019-0750-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825343PMC
November 2019

Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding.

Thromb Res 2019 Oct 2;182:12-19. Epub 2019 Aug 2.

Health Services and Policy Research Institute, Queen's University, Kingston, Canada; Department of Public Health Sciences, Queen's University, Kingston, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2019.07.026DOI Listing
October 2019

What Medical Students Teach: The Healing Skill of Being a Team Player.

Hastings Cent Rep 2019 Sep;49(5):38-47

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hast.1055DOI Listing
September 2019

Can we transfuse wisely in patients undergoing chemotherapy for acute leukemia or autologous stem cell transplantation?

Transfusion 2019 Jul 6;59(7):2308-2315. Epub 2019 May 6.

Department of Medicine, Division of Hematology, Queen's University, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.15335DOI Listing
July 2019

The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.

Breast Cancer Res 2019 04 3;21(1):47. Epub 2019 Apr 3.

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-019-1130-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448248PMC
April 2019

Erosion of informed consent in U.S. research.

Bioethics 2019 01 26;33(1):4-12. Epub 2018 Nov 26.

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bioe.12532
Publisher Site
http://dx.doi.org/10.1111/bioe.12532DOI Listing
January 2019

The Over-Medicalization and Corrupted Medicalization of Abortion and its Effect on Women Living in Poverty.

J Law Med Ethics 2018 Sep;46(3):672-679

Lois Shepherd, J.D., is the Peter A. Wallenborn, Jr. and Dolly F. Wallenborn Professor of Biomedical Ethics, Professor of Public Health Sciences, Professor of Law, University of Virginia. Hilary D. Turner, J.D., graduated from University of Virginia in 2018.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1073110518804222DOI Listing
September 2018

Introduction: The Medicalization of Poverty.

J Law Med Ethics 2018 Sep;46(3):563-566

Lois Shepherd, J.D., is the Peter A. Wallenborn, Jr. and Dolly F. Wallenborn Professor of Biomedical Ethics, Professor of Public Health Sciences, and Professor of Law at the University of Virginia. Robin Fretwell Wilson, J.D., is the Roger and Stephany Joslin Professor of Law and the Director of the Epstein Health Law and Policy Program at the University of Illinois College of Law.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1073110518804197DOI Listing
September 2018

, a Novel Transcription Factor and a Coregulator of Nuclear Factor B p65: Single Nucleotide Polymorphism and Estrogen Dependence.

J Pharmacol Exp Ther 2018 06 28;365(3):700-710. Epub 2018 Mar 28.

Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics (M.H., E.L.d.R., C.Z., L.W., H.L., R.M.W.), and Division of Medical Oncology, Department of Oncology (J.N.I.), Mayo Clinic, Rochester, Minnesota; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts (P.E.G.); Canadian Cancer Trials Group, Kingston, Ontario, Canada (L.E.S.); and RIKEN Center for Integrative Medical Science, Yokohama, Japan (M.K.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.118.247718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954488PMC
June 2018

Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-B Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response.

Mol Pharmacol 2017 08 14;92(2):175-184. Epub 2017 Jun 14.

Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics (M.-F.H., L.W., R.M.W.), Division of Medical Oncology, Department of Oncology (J.N.I.), and Division of Biomedical Statistics and Informatics, Department of Health Sciences Research (K.R.K.), Mayo Clinic, Rochester, Minnesota; Department of Emergency Medicine, Vanderbilt Medical Center, Nashville, Tennessee (T.B.); Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts (P.E.G.); NCIC Clinical Trials Group, Kingston, Ontario Canada (L.E.S.); and RIKEN Center for Integrative Medical Science, Tsurumi-ku, Yokohama, Japan (T.M., M.K.)

View Article

Download full-text PDF

Source
http://molpharm.aspetjournals.org/lookup/doi/10.1124/mol.117
Publisher Site
http://dx.doi.org/10.1124/mol.117.108340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508195PMC
August 2017

Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.

Chest 2017 07 17;152(1):81-91. Epub 2017 Feb 17.

Centre for Health Services and Policy Research, Queen's University, Kingston, ON, Canada; Department of Public Health Sciences, Queen's University, Kingston, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2017.02.009DOI Listing
July 2017

Leukocytoclastic vasculitis following lenalidomide during the treatment of follicular lymphoma.

Leuk Lymphoma 2017 03 25;58(3):711-714. Epub 2016 Aug 25.

a Division of Medical Oncology , BC Cancer Agency , Vancouver , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1204657DOI Listing
March 2017

The hair stylist, the corn merchant, and the doctor: ambiguously altruistic.

Authors:
Lois Shepherd

J Law Med Ethics 2014 ;42(4):509-17

Wallenborn Professor of Biomedical Ethics at the University of Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jlme.12172DOI Listing
November 2016

A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma.

Blood 2016 08 23;128(5):732-5. Epub 2016 Jun 23.

Biology, University of New Brunswick, Saint John, NB, Canada; Department of Oncology, Saint John Regional Hospital, Dalhousie University and University of New Brunswick, Saint John, NB, Canada.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2016-06-71
Publisher Site
http://dx.doi.org/10.1182/blood-2016-06-716902DOI Listing
August 2016

Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.

Clin Cancer Res 2016 05;22(10):2435-44

Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia. School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0414DOI Listing
May 2016

Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.

Mol Endocrinol 2016 Mar 11;30(3):382-98. Epub 2016 Feb 11.

Division of Clinical Pharmacology (M.-F.H., M.L., L.W., R.M.W.), Department of Molecular Pharmacology and Experimental Therapeutics, Division of Rheumatology (M.-F.H., T.B.), Department of Medicine, Division of Biomedical Statistics and Informatics (K.R.K.), Department of Health Sciences Research, and Division of Medical Oncology (M.P.G., J.N.I.), Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905; Division of Hematology/Oncology (P.E.G.), Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard University, Boston, Massachusetts 02114; National Cancer Institute of Canada Clinical Trials Group (L.E.S.), Kingston, Ontario, Canada K7L 3N6; and RIKEN Center for Integrative Medical Science (M.K.), Yokohama 230-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/me.2015-1267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771694PMC
March 2016

SUPPORT and Comparative Effectiveness Trials: What's at Stake?

Authors:
Lois Shepherd

Hastings Cent Rep 2015 Jan-Feb;45(1):44-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hast.417DOI Listing
August 2015

Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy.

Breast Cancer Res Treat 2015 Aug 25;153(1):135-44. Epub 2015 Jul 25.

Department of Chemistry and Biochemistry, Laurentian University, 935 Ramsey Lake Rd., Sudbury, ON, P3E 2C6, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3498-9DOI Listing
August 2015

Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12.

J Natl Cancer Inst 2015 Jul 13;107(7). Epub 2015 Apr 13.

Affiliations of authors: Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada (MCC, KRI, SH, NM); NCIC Clinical Trials Group, Kingston, Ontario, Canada (AEH, YS, NR, LS, AL, BEC, NM); Princess Margaret Cancer Centre, Toronto, Ontario, Canada (MC, VK); Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, Ontario, Canada (JS, CTK, RMM); Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (SC, DM); Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario, Canada (TB); Cancercare Manitoba, Winnipeg, Manitoba, Canada (DS); Hopital Charles Lemoyne, Montreal, Quebec, Canada (PD).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv106DOI Listing
July 2015

What Is Reasonably Foreseeable? Lessons Learned From the SUPPORT Trial.

Int J Radiat Oncol Biol Phys 2015 Jul;92(4):718-20

Center for Biomedical Ethics and Humanities, University of Virginia, Charlottesville, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2015.03.006DOI Listing
July 2015

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.

J Clin Oncol 2015 May 16;33(14):1574-83. Epub 2015 Mar 16.

Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver; Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia; Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec; Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston; Susan Dent, Ottawa Health Research Institute, Ottawa; Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto; Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario; Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada; Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia; Bella Kaufman, Sheba Medical Centre, Tel Hashomer; Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel; Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg; Sergei Tjulandin, Russian Cancer Research Center, Moscow; Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia; Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy; Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain; Lee S. Schwartzberg, West Clinic, Memphis, TN; Arnd Nusch, Praxis, Velbert, Germany; Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom; Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan; Anne P. Connor, GlaxoSmithKline, Collegeville, PA; and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/14/1574.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.9590
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.9590DOI Listing
May 2015

Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.

J Clin Oncol 2015 May 20;33(15):1680-7. Epub 2015 Apr 20.

John M.S. Bartlett, Ontario Institute for Cancer Research; Frances P. O'Malley, St Michael's Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto; John M.S. Bartlett, Frances P. O'Malley, and Lois E. Shepherd, National Cancer Institute of Canada Clinical Trials Group; Lois E. Shepherd, Queen's University, Kingston, Canada; John M.S. Bartlett, Alison F. Munro, and David A. Cameron, University of Edinburgh, Edinburgh; Christopher C. McConkey, Janet A. Dunn, and Christopher J. Poole, University of Warwick, Coventry; Helena M. Earl and Carlos Caldas, University of Cambridge, Cambridge; Christopher J. Twelves, St James's University Hospital, Leeds; Daniel W. Rea, University of Birmingham, Birmingham, United Kingdom; Christine Desmedt and Denis P. Larsimont, Université Libre de Bruxelles, Brussels, Belgium; Fatima Cardoso, Champalimaud Cancer Centre, Lisbon, Portugal; Maj-Britt Jensen and Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; and Angelo Di Leo, Hospital of Prato, Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.7869DOI Listing
May 2015

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Oncologist 2015 May 23;20(5):474-82. Epub 2015 Apr 23.

Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425383PMC
May 2015

Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.

J Natl Cancer Inst 2015 Mar 4;107(3). Epub 2015 Mar 4.

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (PJG); NCIC Clinical Trials Group, Cancer Research Institute, Queen's University, Kingston, Ontario, Canada (WRP, LES, BEC); NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada (KAG); Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (JAL); Columbia University Medical Center, New York, NY (DLH); National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA (PR); Vanderbilt-Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN (IAM); Mayo Clinic College of Medicine, Rochester, MN (TJH); Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint-Sacrement, Quebec, Quebec, Canada (JL); National Cancer Research Institute Breast Clinical Studies Group, London, UK (AMT); Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada (KIP); Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (TJW, SDM); Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (HIC); British Columbia Cancer Agency, Fraser Valley Center, Surrey, British Columbia, Canada (CDO); University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada (KST); British Columbia Cancer Agency - Vancouver Island Center, University of British Columbia, British Columbia, Canada (VB); Ontario Cancer Institute, University Health Network, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (VS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565534PMC
March 2015

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.

J Clin Oncol 2015 Jan 15;33(3):265-71. Epub 2014 Dec 15.

Vered Stearns, Kimmel Cancer Center, Johns Hopkins, Baltimore, MD; Judith-Anne W. Chapman, Aurélie Le Maitre, Jessica Kundapur, and Lois E. Shepherd, NCIC Clinical Trials Group, Queen's University, Kingston; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Cynthia X. Ma, Siteman Cancer Center, Washington University, St Louis, MO; Matthew J. Ellis, Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX; James N. Ingle, Mayo Clinic, Rochester, MN; G. Thomas Budd, Cleveland Clinic, Cleveland, OH; George W. Sledge, Stanford University, San Francisco, CA; Pedro E.R. Liedke and Paul E. Goss, Harvard University; Paul E. Goss, Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA; Manuela Rabaglio, Inselspital University Hospital and International Breast Cancer Study Group Coordinating Center, Berne, Switzerland; and Pedro E.R. Liedke, Hospital de Clínicas de Porto Alegre and Instituto do Cancer Mãe de Deus, Oncologia, Porto Alegre, Rio Grande do Sul, Brazil.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/3/265.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.6926
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.6926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289722PMC
January 2015

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.

J Clin Oncol 2014 Nov 29;32(31):3490-6. Epub 2014 Sep 29.

Michael Crump, John Kuruvilla, and Vishal Kukreti, Princess Margaret Cancer Centre; Rena Buckstein and Kevin R. Imrie, Odette Cancer Centre and Sunnybrook Health Sciences Centre, Toronto; C. Tom Kouroukis, Jonathan Sussman, and Ralph M. Meyer, Margaret and Charles Juravinski Cancer Centre, Hamilton; Kang Howson-Jan, London Health Sciences Centre, London; Tara Baetz, Cancer Centre of Southeastern Ontario at Kingston General Hospital; Annette E. Hay, Marina S. Djurfeldt, Ralph M. Meyer, Bingshu E. Chen, and Lois E. Shepherd, NCIC Clinical Trials Group, Kingston; Leonard Kaizer, Credit Valley Hospital, Mississauga, Ontario; Stephen Couban and David A. MacDonald, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Morel Rubinger, Cancercare Manitoba, Winnipeg, Manitoba; Michael Voralia, Saskatoon Cancer Centre, Saskatoon, Saskatchewan; Harold J. Olney, Centre Hospitalier de l'Université de Montréal-Hopital Notre Dame, Montreal, Quebec; A. Robert Turner, Cross Cancer Institute, Edmonton, Alberta, Canada; Massimo Federico, University of Modena and Reggio Emilia, Modena; Nicola Di Renzo, Ospedale Vito Fazzi, Leece, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.9593DOI Listing
November 2014

Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.

Mol Endocrinol 2014 Oct 22;28(10):1740-51. Epub 2014 Aug 22.

Division of Clinical Pharmacology (M.L., L.W., R.M.W.), Department of Molecular Pharmacology and Experimental Therapeutics; Departments of Oncology (J.N.I.) and Health Sciences Research (A.B., G.D.J., E.E.C., D.J.S.); and Division of Endocrinology (S.K.), Mayo Clinic, Rochester, Minnesota 55905; Massachusetts General Hospital (P.E.G.), Harvard University, Boston, Massachusetts 02114; Rikagaku Kenkyūsho Center for Integrative Medical Science (M.K., Y.F.), Yokohama, Japan 230-0045; School of Medicine (Y.N.), Chicago University, Chicago, Illinois 60637; National Cancer Institute of Canada Clinical Trials Group (J.-A.W.C., L.E.S.), Kingston, Ontario, Canada K7L 3N6; and Division of Oncology (M.J.E.), Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/me.2014-1147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179631PMC
October 2014

A practical tool for modeling biospecimen user fees.

Biopreserv Biobank 2014 Aug;12(4):234-9

1 University of British Columbia Office of Biobank Education and Research , Vancouver, British Columbia, Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2014.0008DOI Listing
August 2014

Informed consent and standard of care: what must be disclosed.

Am J Bioeth 2013 ;13(12):9-13

a Albert Einstein College of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15265161.2013.849303DOI Listing
June 2014

In plain sight: a solution to a fundamental challenge in human research.

J Law Med Ethics 2012 ;40(4):970-89

University of Virginia, School of Law, the Department of Public Health Sciences, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1748-720X.2012.00725.xDOI Listing
January 2014

Reply to e. Esin et al.

J Clin Oncol 2013 Sep 5;31(27):3439-40. Epub 2013 Aug 5.

Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4893DOI Listing
September 2013

Children enrolled in parents' research: a uniquely vulnerable group in need of oversight and protection.

IRB 2013 May-Jun;35(3):1-8

School of Law, University of Virginia, Charlottesville, VA, USA.

View Article

Download full-text PDF

Source
July 2013

Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.

Breast Cancer Res Treat 2012 Dec 23;136(3):769-76. Epub 2012 Oct 23.

Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2294-z
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2294-zDOI Listing
December 2012

Ready to listen: why welcome matters.

J Pain Symptom Manage 2012 Mar;43(3):646-50

Center for Biomedical Ethics and Humanities, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08853924110077
Publisher Site
http://dx.doi.org/10.1016/j.jpainsymman.2011.09.004DOI Listing
March 2012

Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial.

Breast Cancer Res Treat 2012 Jan 1;131(2):541-51. Epub 2011 Nov 1.

Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1840-4DOI Listing
January 2012

The HPV vaccine and parental consent.

Virtual Mentor 2012 Jan 1;14(1):5-12. Epub 2012 Jan 1.

Department of Public Health Sciences, University of Virginia School of Medicine in Charlottesville, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/virtualmentor.2012.14.1.ccas1-1201DOI Listing
January 2012

Advising patients about obtaining genomic profiles.

Neurol Clin Pract 2011 Dec;1(1):5-13

Center for Biomedical Ethics and Humanities (DTC, LLS), Department of Public Health Sciences (DTC, LLS), Department of Psychiatry and Neurobehavioral Sciences (DTC), and School of Law (LLS), Center for Biomedical Ethics and Humanities, University of Virginia Health System, Charlottesville.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0b013e31823cd13cDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613189PMC
December 2011

Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14.

J Clin Oncol 2011 Sep 22;29(27):3605-10. Epub 2011 Aug 22.

Penn State Hershey Cancer Institute, Division of Hematology/Oncology, Penn State Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2010.31.5069
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.31.5069DOI Listing
September 2011

Ringer's lactate is compatible with saline-adenine-glucose-mannitol preserved packed red blood cells for rapid transfusion.

Can J Anaesth 2010 Dec 5;57(12):1071-7. Epub 2010 Oct 5.

Department of Anesthesiology and Perioperative Medicine, Queen's University, Kingston General Hospital, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12630-010-9396-zDOI Listing
December 2010

Asking too much: autonomy and responsibility at the end of life.

Authors:
Lois Shepherd

J Contemp Health Law Policy 2009 ;26(1):72-81

University of Virginia, USA.

View Article

Download full-text PDF

Source
March 2010

Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients.

Breast Cancer Res Treat 2010 Jan;119(2):347-56

Regional Cancer Program, Sudbury Regional Hospital, Laurentian University, Sudbury, ON P3E 5J1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0531-xDOI Listing
January 2010

The real me?

Authors:
Lois Shepherd

Hastings Cent Rep 2009 Jul-Aug;39(4):5-6; author reply 6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1353/hcr.0.0166DOI Listing
October 2009

When, why, and how to conduct research in child and adolescent psychiatry: practical and ethical considerations.

Psychiatr Clin North Am 2009 Jun;32(2):361-80

Center for Biomedical Ethics and Humanities, University of Virginia School of Medicine, Box 800758, Hospital Drive, Barringer 5th Floor, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psc.2009.03.003DOI Listing
June 2009